Related Experiment Video
Updated: Nov 27, 2025

A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Published on: January 7, 2020
A macrophage-specific lncRNA regulates apoptosis and atherosclerosis by tethering HuR in the nucleus
Viorel Simion1, Haoyang Zhou1,2, Stefan Haemmig1
1Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Abstract:
Long non-coding RNAs (lncRNAs) are emerging regulators of pathophysiological processes including atherosclerosis. Using RNA-seq profiling of the intima of lesions, here we identify a macrophage-specific lncRNA MAARS (Macrophage-Associated Atherosclerosis lncRNA Sequence). Aortic intima expression of MAARS increases by 270-fold with atherosclerotic progression and decreases with regression by 60%. MAARS knockdown reduces atherosclerotic lesion formation by 52% in LDLR-/- mice, largely independent of effects on lipid profile and inflammation, but rather by decreasing macrophage apoptosis and increasing efferocytosis in the vessel wall. MAARS interacts with HuR/ELAVL1, an RNA-binding protein and important regulator of apoptosis. Overexpression and knockdown studies verified MAARS as a critical regulator of macrophage apoptosis and efferocytosis in vitro, in an HuR-dependent manner. Mechanistically, MAARS knockdown alters HuR cytosolic shuttling, regulating HuR targets such as p53, p27, Caspase-9, and BCL2. These findings establish a mechanism by which a macrophage-specific lncRNA interacting with HuR regulates apoptosis, with implications for a broad range of vascular disease states.
Insights
A newly discovered long non-coding RNA, MAARS, plays a key role in atherosclerosis by regulating macrophage apoptosis and efferocytosis. Targeting MAARS shows potential for treating vascular diseases.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- RNA Biology
Background:
- Long non-coding RNAs (lncRNAs) are increasingly recognized for their roles in disease.
- Atherosclerosis pathogenesis involves complex cellular and molecular events within the arterial wall.
Purpose of the Study:
- To identify novel lncRNAs involved in atherosclerosis.
- To elucidate the function and mechanism of a macrophage-specific lncRNA, MAARS, in atherosclerosis.
Main Methods:
- RNA sequencing of atherosclerotic lesions.
- In vivo studies using LDLR-/- mice.
- In vitro macrophage apoptosis and efferocytosis assays.
- RNA-binding protein immunoprecipitation and Western blotting.
Main Results:
- Identified MAARS, a macrophage-specific lncRNA significantly upregulated in atherosclerotic lesions.
- MAARS knockdown reduced lesion formation by 52% in mice, primarily by decreasing macrophage apoptosis and enhancing efferocytosis.
- MAARS interacts with HuR/ELAVL1, regulating its cytosolic localization and downstream targets involved in apoptosis (p53, p27, Caspase-9, BCL2).
Conclusions:
- MAARS is a critical regulator of macrophage apoptosis and efferocytosis in atherosclerosis via HuR.
- MAARS represents a potential therapeutic target for vascular diseases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Regulation of Nuclear Protein Sorting
The Extrinsic Apoptotic Pathway
Inflammation
Apoptosis

